ResearcherAnhui Medical UniversityNo recent work listed
Jiong Chen
Matched on ORCID iD 0000-0001-9389-520X; OpenAlex author ID A5030441807. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2013: 5 papers · 2014: 2 papers · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 10
- Specificity protein 1-activated bone marrow stromal cell antigen 2 accelerates pancreatic cancer cell proliferation and migration. Last author DOI 10.3892/etm.2021.10894↗
- Expression and prognostic significance of unique ULBPs in pancreatic cancer. Co-author DOI 10.2147/ott.s107771↗
- Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer. Last author DOI 10.2147/tcrm.s96869↗
- Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review. Co-author DOI 10.1007/s00432-014-1728-x↗
- [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. Co-author PMID 25331466↗
- Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-013-1422-4↗
- Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12032-013-0583-y↗
- Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycopr… Co-author DOI 10.1016/j.pan.2013.03.010↗
- Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. Co-author DOI 10.3892/ol.2013.1326↗
- [Analysis of pancreatic cancer peripheral blood by comparative proteomics]. Co-author PMID 23578431↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ren-bao Yang · 7 shared papers, 2013–2014 · strength 0.28
- Paper Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review. DOI 10.1007/s00432-014-1728-x↗
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation… DOI 10.1016/j.pan.2013.03.010↗
- Longjiang Chen · 6 shared papers, 2013–2014 · strength 0.23
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation… DOI 10.1016/j.pan.2013.03.010↗
- Paper Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. DOI 10.3892/ol.2013.1326↗
- Liwei Hu · 6 shared papers, 2013–2014 · strength 0.23
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation… DOI 10.1016/j.pan.2013.03.010↗
- Paper Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. DOI 10.3892/ol.2013.1326↗
- Chun Lei · 1 shared paper, 2021 · strength 0.22
- Hongxia Xu · 2 shared papers, 2016 · strength 0.17
- Yue Zhao · 3 shared papers, 2013–2014 · strength 0.12
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-013-1422-4↗
- Paper Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-013-0583-y↗
- Jin-Qian Zhao · 1 shared paper, 2016 · strength 0.08
- YouQian Zhang · 1 shared paper, 2014 · strength 0.05
- Liang Li · 1 shared paper, 2014 · strength 0.05
- Yue Zhao · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.